Discover
WVE
Wave Life Sciences Ltd.
5.78
12 x 5.77
23 x 5.78
bid
ask
-
0.29
4.85%
12:37 PM
timesize
| Ytd | -66.03% | |
| 1y | -28.79% |
5.76
day range
6.12
5.02
52 week range
21.73
| Open | 6.08 | Prev Close | 6.07 | Low | 5.76 | High | 6.12 | Mkt Cap | 1.14B |
| Vol | 862.63K | Avg Vol | 3.23M | EPS | -1.06 | P/E | -5.45 | Forward P/E | -5.12 |
| Beta | -1.26 | Short Ratio | 5.31 | Inst. Own | 83.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 5.93 | 200-d Avg | 9.54 | 1yr Est | 19.06 |
| Income Statement | |||
| Total Revenue | 2.27M | ||
| Revenues (USD) | 2.27M | ||
| Gross Profit | 2.27M | ||
| Operating Expenses | 76.07M | ||
| Research and Development Expense | 51.29M | ||
| Selling, General and Administrative Expense | 24.78M | ||
| Operating Income | -73.80M | ||
| Net Income | -69.35M | ||
| Net Income Common Stock | -69.35M | ||
| Net Income Common Stock (USD) | -69.35M | ||
| Consolidated Income | -69.35M | ||
| Earnings per Basic Share | -0.34 | ||
| Earnings per Basic Share (USD) | -0.34 | ||
| Earnings per Diluted Share | -0.34 | ||
| Earning Before Interest & Taxes (EBIT) | -69.35M | ||
| Earning Before Interest & Taxes (USD) | -69.35M | ||
| Weighted Average Shares | 204.01M | ||
| Weighted Average Shares Diluted | 204.01M | ||
| Balance Sheet | |||
| Cash and Equivalents | 368.01M | ||
| Cash and Equivalents (USD) | 368.01M | ||
| Investments | 126.41M | ||
| Investments Current | 122.59M | ||
| Investments Non-Current | 3.82M | ||
| Trade and Non-Trade Receivables | 888.00K | ||
| Current Assets | 507.51M | ||
| Property, Plant & Equipment Net | 46.33M | ||
| Total Assets | 558.32M | ||
| Debt Current | 3.51M | ||
| Total Debt | 43.59M | ||
| Current Liabilities | 50.82M | ||
| Debt Non-Current | 40.08M | ||
| Total Liabilities | 104.80M | ||
| Accumulated Retained Earnings (Deficit) | -1.42B | ||
| Accumulated Other Comprehensive Income | -172.00K | ||
| Shareholders Equity | 453.52M | ||
| Shareholders Equity (USD) | 453.52M | ||
| Assets Non-Current | 50.81M | ||
| Total Debt (USD) | 43.59M | ||
| Deferred Revenue | 22.61M | ||
| Liabilities Non-Current | 53.99M | ||
| Trade and Non-Trade Payables | 20.36M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.37M | ||
| Net Cash Flow from Financing | 330.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -176.58M | ||
| Capital Expenditure | -884.00K | ||
| Issuance (Purchase) of Equity Shares | 330.00K | ||
| Net Cash Flow from Investing | -123.45M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -122.57M | ||
| Net Cash Flow from Operations | -53.58M | ||
| Effect of Exchange Rate Changes on Cash | 123.00K | ||
| Share Based Compensation | 10.73M | ||